About Contact Us Careers
Sign In

Breast Biopsy Market Size & Share, by Product (Biopsy Needles, Biopsy Tables, Biopsy Wires), End-user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2025-2037

  • Report ID: 747
  • Published Date: Nov 07, 2024
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2025 - 2037

The Breast Biopsy Market size was valued at USD 3.4 billion in 2024 and is set to exceed USD 7.71 billion by 2037, registering over 6.5% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of breast biopsy is estimated at USD 3.58 billion.

The growth of the market is mainly due to the increasing cases of breast cancer. According to the World Health Organization (WHO), by the end of 2020, 711 million women had been diagnosed with breast cancer in the past 5 years, making it the most common cancer in the world.

In addition, government initiatives around the world to develop and implement new screening programs, raise awareness of treatment options, and organize free camps are expected to be the main driving force for the development of the global market.

Get more information on this report: Request Free Sample PDF

Breast Biopsy Sector: Growth Driver and Challenges

Growth Driver

  • Increasing Consumption of Unhealthy Foods- Breast cancer is increasing globally due to the increasing consumption of unhealthy and fried foods by women worldwide. One study found that women who regularly ate fried food were 4.5 times more likely to develop breast cancer than other women her age, with a very significant association between highly fried foods and the risk of breast cancer.
  • Technological Advances in Breast Biopsy Equipment: Technological advances in breast biopsy devices have led to the development of more precise and less invasive procedures. For example, 3D mammography is becoming increasingly popular because it provides higher-resolution images that can detect smaller lesions. One study found that 3D mammography was associated with a 41% increased chance of detecting invasive breast cancer compared with traditional 2D mammography.
  • Raise Awareness About Breast Cancer Screening: Growing awareness of the importance of early detection and diagnosis of breast cancer, through breast cancer screening, leading to an increase in the number of women undergoing breast biopsy procedures. According to a survey, nearly 75% of women aged 40 and over said they had a mammogram in the past two years. 
  • Increased Spending on Health: Increasing healthcare costs worldwide are driving the growth of the global breast biopsy market. According to a study, global health expenditure was valued at USD 7.1 trillion in 2019 and is expected to reach USD 12.8 trillion by 2026. As healthcare costs continue to rise, more resources will be allocated to breast cancer screening and diagnosis, which will lead to an increase in demand for breast biopsy procedures. 

Challenges

  • High Cost of Breast Biopsy Procedures – Breast biopsy procedures can be expensive, particularly in countries where healthcare costs are high. This can make it difficult for some patients to access the procedure, leading to delays in diagnosis and treatments.
  • Lack of Awareness and Education
  • Fear and Discomfort

Breast Biopsy Market: Key Insights

Base Year

2024

Forecast Year

2025-2037

CAGR

6.5%

Base Year Market Size (2024)

USD 3.4 billion

Forecast Year Market Size (2037)

USD 7.71 billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Breast Biopsy Segmentation

End Users (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers)

The hospital segment in the breast biopsy market is estimated to hold the largest revenue share around 40% between the time period 2023 – 2037. The growth of this segment can be attributed to the large number of patients requiring breast biopsies and hospitalization for surgery or treatment. Hospitals are also experiencing remarkable growth in numbers. For example, in 2022, there are about 6,100 hospitals in the United States. Hospitals provide a wide range of medical care services. Doctors, called hospital physicians, often specialize in internal medicine, pediatrics, or general medicine. They know to solve common problems and have the resources to tackle more complex medical problems.

Product (Biopsy Needles, Biopsy Tables, Biopsy Wires)

The biopsy needle segment is set to hold 30% share of the global breast biopsy market by the end of 2037. The growth of this segment can be attributed to the increasing demand for breast biopsy procedures, including the use of biopsy needles. The growing awareness of the importance of breast biopsy procedures, including the use of biopsy needles. 

Our in-depth analysis of the global market includes the following segments:

 

Product
  • Biopsy Needles
  • Biopsy Tables
  • Biopsy Wires

 

End User
  • Hospitals
  • Ambulatory Surgical Centers
  •  Diagnostic Centers

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Breast Biopsy Landscape – Regional Scope

APAC Market Forecast

The breast biopsies market in Asia Pacific, is expected to hold the largest revenue share of around 35% by the end of 2037. The growth of the region is likely to be mainly due to the increase in the percentage of the aging population in the Asia Pacific region. As older women have a higher risk of breast cancer. Also, health organizations are increasingly promoting breast cancer screening programs, including mammograms and breast biopsies.

North America Market Statistics

The breast biopsy market in the North America is expected to account for the second largest market share, around 25% during the projection period. The growth of the market in this region can be mainly attributed to the increasing technological advancement in breast biopsy technology in North America. There have been significant advances in the design and function of biopsy needles and other biopsy devices in North America, making breast biopsies more precise and less invasive. This has led to an increase in demand for breast biopsy procedures in the region. All insurance plans in North America cover breast biopsy procedures, making the procedure easier for patients to access, leading to increased demand

Research Nester
Get more information on this report: Request Free Sample PDF

Companies Dominating the Breast Biopsy Landscape

    • Hologic, Inc.
    • Company Overview
    • Business Strategy
    • Key Product Offerings
    • Financial Performance
    • Key Performance Indicators
    • Risk Analysis
    • Recent Development
    • Regional Presence
    • SWOT Analysis
    • Danaher Corporation
    • BD (Becton, Dickinson, and Company)
    • Cook Medical LLC
    • Argon Medical Devices, Inc.
    • B. Braun Melsungen AG
    • C.R. Bard, Inc.
    • Devicor Medical Products, Inc.
    • Cardinal Health, Inc.

In the News

  • Hologic Inc, Hologic announced that its subsidiary, Biotheranostics, received a positive coverage determination from Medicare for Its Breast Cancer Index genomic test. The Breast Cancer Index test is used to predict the likelihood of recurrence in early-stage, hormone receptor-positive breast cancer patients.
  • BD (Becton, Dickinson, and Company). BD announced the launch of the BO Intevia 1mL two-step disposable autoinjector, which is used for the subcutaneous injection of biological drugs. The device is designed to enhance patient experience and medication adherence by providing a reliable, easy-to-use, and customizable Infection experience. The BD Intevia autoinjector is part of the company's broader portfolio of products for drug delivery and administration.

Author Credits:  Radhika Pawar


  • Report ID: 747
  • Published Date: Nov 07, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of breast biopsy is estimated at USD 3.58 billion.

The breast biopsy market size was valued at USD 3.4 billion in 2024 and is set to exceed USD 7.71 billion by 2037, registering over 6.5% CAGR during the forecast period i.e., between 2025-2037. The growing incidence of breast cancer and the expansion of healthcare spending will drive the market growth.

Asia Pacific industry is expected to account for largest revenue share of 35% by 2037, impelled by increase in the percentage of the aging population in the region.

The major players in the market include Hologic, Inc., Danaher CorporationBD (Becton, Dickinson, and Company)Cook Medical LLCArgon Medical Devices, Inc.B. Braun Melsungen AGC.R. Bard, Inc.Devicor Medical Products, Inc.Cardinal Health, Inc.
Breast Biopsy Market Report Scope

Copyright © 2024 Research Nester. All Rights Reserved

logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample